gusperimus has been researched along with Angiitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birck, R; Choi, M; Drexler, JM; Göbel, U; Grünke, M; Haubitz, M; Hotta, O; Kalden, JR; Lorenz, HM; Nowack, R; Peter, HH; Van Der Woude, FJ; Warnatz, K | 1 |
| Dillon, MJ | 1 |
| Kallenberg, CG; Stegeman, CA; Tervaert, JW | 1 |
2 review(s) available for gusperimus and Angiitis
| Article | Year |
|---|---|
Vasculitis treatment - new therapeutic approaches.
Topics: Antibodies, Monoclonal; B-Lymphocytes; Guanidines; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infliximab; Lymphocyte Depletion; Mycophenolic Acid; Plasma Exchange; T-Lymphocytes; Vasculitis | 2006 |
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antilymphocyte Serum; Cyclophosphamide; Guanidines; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Isoxazoles; Kidney Diseases; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisone; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Vasculitis | 2001 |
1 other study(ies) available for gusperimus and Angiitis
| Article | Year |
|---|---|
15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Drug Administration Schedule; Female; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunosuppressive Agents; Leukocyte Count; Leukopenia; Male; Middle Aged; Pilot Projects; Safety; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis | 2003 |